Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25105532 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Kanellos Koustenis und 6 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Department, Evangelismos-Polykliniki General Hospital, 115 27 Athens, Greece. Hauptthemen laut MEDLINE: Ustekinumab, Colitis, Ulcerative, Computational Biology. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hellenic Group for the Study of Inflammatory Bowel Diseases (EOMIFNE).
Abstract (Originalsprache)
Introduction
Optimizing treatment with biological agents is an ideal goal for patients with ulcerative colitis (UC). Recent data suggest that mucosal inflammation patterns and serum cytokine profiles differ between patients who respond and those who do not. Ustekinumab, a monoclonal antibody targeting the p40 subunit of interleukin (IL)-12 and IL-23, has shown promise, but predicting treatment response remains a challenge. We aimed to identify prognostic markers of response to ustekinumab in patients with active UC, utilizing information from their mucosal transcriptome.
Methods
We performed a prospective observational study of 36 UC patients initiating treatment with ustekinumab. Colonic mucosal biopsies were obtained before treatment initiation for a gene expression analysis using a microarray panel of 84 inflammatory genes. A differential gene expression analysis (DGEA), correlation analysis, and network centrality analysis on co-expression networks were performed to identify potential biomarkers. Additionally, machine learning (ML) models were employed to predict treatment response based on gene expression data.
Results
Seven genes, including BCL6, CXCL5, and FASLG, were significantly upregulated, while IL23A and IL23R were downregulated in non-responders compared to responders. The co-expression analysis revealed distinct patterns between responders and non-responders, with key genes like BCL6 and CRP highlighted in responders and CCL11 and CCL22 in non-responders. The ML algorithms demonstrated a high predictive power, emphasizing the significance of the IL23R, IL23A, and BCL6 genes.
Conclusions
Our study identifies potential biomarkers associated with ustekinumab response in UC patients, shedding light on its underlying mechanisms and variability in treatment outcomes. Integrating transcriptomic approaches, including gene expression analyses and ML, offers valuable insights for personalized treatment strategies and highlights avenues for further research to enhance therapeutic outcomes for patients with UC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology Department, Evangelismos-Polykliniki General Hospital, 115 27 Athens, Greece.
- Laboratory of Biology, Department of Basic Medical Sciences, Medical School, National and Kapodistrian University of Athens, Michalakopoulou 176, 115 27 Athens, Greece.
- Gastroenterology Unit, Alexandra Hospital, 115 28 Athens, Greece.
- GI-Unit, 3rd Academic Department of Internal Medicine, National and Kapodistrian University of Athens, Sotiria Hospital, 115 27 Athens, Greece.
- Gastroenterology Unit, Second Department of Surgery, Aretaieio Hospital, Medical School, National and Kapodistrian University of Athens, 115 27 Athens, Greece.
ORCID-Profile: Nikolas Dovrolis, Nikos Viazis, Maria Gazouli
Förderung
- Hellenic Group for the Study of Inflammatory Bowel Diseases (EOMIFNE)
Zitieren
APA
Koustenis, K., Dovrolis, N., Viazis, N., Ioannou, A., Bamias, G., Karamanolis, G., & Gazouli, M. (2024). Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25105532
Vancouver
Koustenis K, Dovrolis N, Viazis N, Ioannou A, Bamias G, Karamanolis G, et al. Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25105532
BibTeX
@article{Koustenis2024,
author = {Koustenis, Kanellos and Dovrolis, Nikolas and Viazis, Nikos and Ioannou, Alexandros and Bamias, Giorgos and Karamanolis, George and Gazouli, Maria},
title = {Insights into Therapeutic Response Prediction for Ustekinumab in Ulcerative Colitis Using an Ensemble Bioinformatics Approach},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25105532}
}
EUVIMED